Detalhe da pesquisa
1.
Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease.
J Inherit Metab Dis
; 35(3): 513-20, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-22187137